Table 3.
Evaluation of Lung Involvement in 55 COVID-19 Patients With Suspected Pulmonary Vascular Thrombosis
| Disease Burden (%) | GGO (%) | GGO Ratio (%) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall (n = 55) | LT (n = 28) | Non-LT (n = 27) | p Value* | Overall (n = 55) | LT (n = 28) | Non-LT (n=27) | p Value* | Overall (n = 55) | LT (n = 28) | Non-LT (n = 27) | p Value* | |
| Lungs | ||||||||||||
| Both (RL + LL) | 74.75 (55.45-83.57) | 73.00 (33.80-82.40) | 75.40 (57.20-85.90) | 0.35 | 22.20 (11.50-36.02) | 31.70 (22.90-41.00) | 17.80 (10.80-22.10) | <0.001 | 36.88 (23.58-64.79) | 57.77 (42.99-71.90) | 27.26 (14.50-33.91) | <0.001 |
| RL | 72.35 (49.62-81.97) | 62.20 (36.90-78.70) | 77.70 (53.20-83.50) | 0.36 | 21.50 (13.55-30.55) | 30.20 (21.50-41.00) | 16.80 (11.60-22.00) | <0.001 | 39.37 (22.65-65.11) | 64.97 (41.03-72.35) | 27.46 (17.39-34.69) | <0.001 |
| LL | 76.30 (57.67-88.82) | 77.20 (36.60-89.50) | 75.40 (60.80-88.60) | 0.51 | 20.30 (11.27-31.60) | 29.10 (20.10-48.10) | 16.20 (8.40-20.70) | <0.001 | 36.08 (21.76-63.13) | 62.31 (46.46-72.90) | 24.38 (12.64-33.39) | <0.001 |
| Lobes | ||||||||||||
| RUL | 67.20 (36.87-85.55) | 65.50 (28.30-79.00) | 71.50 (46.00-86.10) | 0.35 | 23.65 (11.55-32.72) | 30.10 (15.00-47.10) | 20.30 (10.70-25.60) | <0.001 | 45.83 (30.77-71.62) | 70.75 (50.53-83.75) | 34.82 (13.83-44.67) | <0.001 |
| RML | 45.70 (20.65-69.55) | 31.70 (17.30-59.80) | 50.40 (26.00-73.30) | 019 | 16.95 (11.65-29.55) | 23.10 (11.80-40.80) | 14.20 (11.20-20.10) | <0.001 | 53.77 (32.20-80.67) | 80.21 (72.06-86.15) | 37.30 (27.15-52.54) | <0.001 |
| RLL | 84.55 (68.35-95.17) | 84.20 (59.80-94.40) | 87.50 (74.80-96.30) | 0.41 | 19.95 (11.72-31.87) | 29.00 (23.20-43.20) | 13.80 (8.60-17.80) | <0.001 | 29.22 (14.59-56.94) | 48.10 (31.56-70.47) | 15.41 (11.54-24.64) | <0.001 |
| LUL | 71.90 (35.62-83.95) | 69.60 (26.70-84.40) | 74.80 (42.80-80.70) | 0.71 | 21.15 (12.15-40.62) | 35.70 (16.30-50.70) | 15.50 (10.80-24.60) | <0.001 | 47.51 (28.77-72.06) | 71.88 (53.66-77.80) | 35.83 (15.54-47.07) | <0.001 |
| LLL | 88.30 (71.80-95.47) | 80.70 (53.30-95.30) | 89.60 (77.60-96.00) | 0.34 | 19.85 (9.77-31.2) | 31.00 (21.60-38.60) | 11.70 (5.00 -19.20) | <0.001 | 29.98 (12.81-49.36) | 43.15 (30.11-65.36) | 13.41 (8.33-27.99) | <0.001 |
NOTE. Results reported as frequency (%) and range.
Abbreviations: COVID-19, coronavirus disease 2019; GGO, ground-glass opacities; LL, left lobe; LLL, left lower lobe; LT, lung thrombosis; LUL, left lower lobe; RL, right lobe; RLL, right lower lobe; RML, right middle lobe; RUL, right upper lobe.
⁎
P values are calculated by chi-square or Fisher exact test (categorical variables) or Mann Whitney test (continuous variables).